Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Apr 14, 2023
Date Accepted: Dec 14, 2023

The final, peer-reviewed published version of this preprint can be found here:

Mobile Mindfulness Meditation for Cancer-Related Anxiety and Neuropathy: Protocol for a Randomized Controlled Trial

Orasud AS, Bantum EO, Uchiyama M

Mobile Mindfulness Meditation for Cancer-Related Anxiety and Neuropathy: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2024;13:e47745

DOI: 10.2196/47745

PMID: 38345843

PMCID: 10897800

Mobile Mindfulness Meditation for Cancer-Related Anxiety and Neuropathy: Protocol for a Randomized Controlled Trial

  • Ariel Siritorn Orasud; 
  • Erin O'Carroll Bantum; 
  • Mai Uchiyama

ABSTRACT

Background:

Anxiety and cancer related neuropathy are two persistent effects related to treatment for cancer. Mindfulness meditation has been used with substantial impact as a non-pharmacologic intervention to mitigate side and late effects of treatment. Mobile apps are ubiquitous for most of the general population, yet have a particular relevance for cancer survivors, given that physical and geographic limitations can be present.

Objective:

The goal of the current manuscript is to describe an ongoing trial of the Mindfulness Coach mobile application (“app”) for cancer survivors.

Methods:

In this randomized wait-list controlled trial, cancer survivors experiencing anxiety or cancer related neuropathy (200 in each arm) and who have finished primary treatment for cancer are invited to participate. Data are collected at three time points regardless of randomization condition: baseline, 8 weeks, and 16 weeks. Both face-to-face and online recruitment strategies have been employed. In addition to evaluating the impact of mobile mindfulness of anxiety or cancer related neuropathy, other pain, fatigue, trauma, sleep, and satisfaction with the Mindfulness Coach app will also be assessed.

Results:

-

Conclusions:

Mindfulness meditation is becoming widely used by the general public, in addition to the use of mobile technology. Finding ways to deliver mindfulness meditation to people who have been treated for cancer allows for the intervention to be accessible to a larger breadth of survivors. The results of this intervention will have implications for further understanding the impact of mindfulness meditation on two persistent side and late effects of treatment of cancer— anxiety and cancer related neuropathy.


 Citation

Please cite as:

Orasud AS, Bantum EO, Uchiyama M

Mobile Mindfulness Meditation for Cancer-Related Anxiety and Neuropathy: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2024;13:e47745

DOI: 10.2196/47745

PMID: 38345843

PMCID: 10897800

The author of this paper has made a PDF available, but requires the user to login, or create an account.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.